Downstream Issues Still Beset Production
To Protect the Bottom Line, Biomanufacturers Invest in Downstream Purification Technology
GEN Roundup: No Detail Is Too Small in Bioprocess Scaleup
A Change in Scale Can Change Everything
Amid Election Clamor, Research Issues Surface
Sounds of Science Podcast
10 Takeover Targets of 2016
Which Biopharmas Do Wall Street Watchers View As Top Buyout Candidates?
Female Sexual Dysfunction Drugs
While men have had Viagra, Cialis, and Levitra to address their sexual dysfunction issues for about a decade, finding a solution for women’s woes has been more complicated. The market for female sexual dysfunction (FSD) drugs is believed larger than the market for male sexual dysfunction treatments, yet despite this no FDA-approved treatments for FSD exist—though several drug developers are closer than ever to changing that. Once approved, how much of a rise do you think they’ll get in sales compared to ED drugs?